RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis
ConclusionsRASSF1A promoter methylation may be associated with cervical cancer development, progression and metastasis. MethylatedRASSF1A may be a noninvasive blood or cytology biomarker. Based on TSA, more studies are essential in the future.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Cytology | Databases & Libraries | Genital Warts | Human Papillomavirus (HPV) | OBGYN | Skin Cancer | Squamous Cell Carcinoma | Study